天弘医药创新A(010654)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-109,181,364.35 |
-254,659,819.04 |
-168,479,562.71 |
-177,836,234.49 |
利息合计 |
373,837.10 |
182,964.46 |
498,393.08 |
270,193.99 |
其中:存款利息收入 |
373,837.10 |
182,964.46 |
498,393.08 |
270,193.99 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-211,604,048.85 |
-198,586,790.73 |
-18,193,707.65 |
-43,517,733.76 |
其中:股票投资收益 |
-221,830,620.47 |
-205,742,698.86 |
-26,350,018.46 |
-49,778,798.51 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
- |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
10,226,571.62 |
7,155,908.13 |
8,156,310.81 |
6,261,064.75 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
101,046,422.89 |
-56,322,687.07 |
-151,385,603.33 |
-134,983,910.32 |
其他收入 |
1,002,424.51 |
66,694.30 |
601,355.19 |
395,215.60 |
费用 |
13,051,589.57 |
6,307,235.73 |
17,099,800.11 |
9,236,173.85 |
管理人报酬 |
9,545,459.69 |
4,617,009.79 |
12,303,399.03 |
6,550,949.43 |
基金托管费 |
1,909,091.93 |
923,401.94 |
2,814,178.11 |
1,637,737.36 |
销售服务费 |
1,365,297.48 |
647,666.05 |
1,738,278.90 |
925,795.40 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
231,740.47 |
119,157.95 |
243,944.07 |
121,691.66 |
利润总额 |
-122,232,953.92 |
-260,967,054.77 |
-185,579,362.82 |
-187,072,408.34 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年